Sickle cell disease status and outcomes of African-American men presenting with priapism.
about
Medical management of ischemic stuttering priapism: a contemporary review of the literatureEstablishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism.Excess adenosine A2B receptor signaling contributes to priapism through HIF-1α mediated reduction of PDE5 gene expressionRandomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease.Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapismManagement of priapism: an update for clinicians.Priapism in sickle-cell disease: a hematologist's perspective.The Measure of Sickle Cell Stigma: Initial findings from the Improving Patient Outcomes through Respect and Trust studyEffort required to contact primary care providers after newborn screening identifies sickle cell trait.Evaluation and management of priapism: 2009 updateAdenosine signaling in normal and sickle erythrocytes and beyond.How I treat priapism.Priapism in sickle cell anemia: emerging mechanistic understanding and better preventative strategies.Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors.Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue.Role of Penile Prosthesis in Priapism: A Review.Duration of priapism is associated with increased corporal oxidative stress and antioxidant enzymes in a rat model.Penile implant surgery
P2860
Q26851728-AAB778E1-A75F-4C0A-888B-97D406998CC4Q33572814-08FB20D0-AA1A-460C-973A-85930E820054Q33613207-22A7CEBA-18E7-49B2-902C-7516576BB1E0Q33859035-A1E50C40-8845-4CB0-A5B7-C8D8F1BF0FB7Q34005421-E38DA672-9E28-4466-B439-C5172A577E94Q34536704-99172E51-9F06-44FC-97DC-DC5CECEBFC13Q35658625-CCBB88F0-2B72-40A8-B4A7-B9188DB7A418Q36233618-A268022E-4CAE-4D44-A009-396D90925AEBQ37433370-54826E9A-FDD1-4D44-B5E9-D95FEFD47F68Q37474332-A64741F6-97F7-4FA6-8AB5-75309F588C20Q38013492-677758A7-3D14-42B6-88F5-1375FBC74BCAQ39025090-13B6EBE2-C39B-4CED-9227-ACE92C8459E8Q39760861-EAC26925-9369-400F-9C20-F66BC5D4C44AQ40852821-97945BE9-DA16-42CB-9A9E-2583AD8888BDQ42696988-10BB0E8F-2026-4B51-98CA-8F3BA8E78A8FQ47211172-63D78412-BA7C-487F-AA76-B1E3D48DDCB8Q51828917-5155E00B-22D9-41DB-8B91-8BA8965C938BQ56928463-2C318BE0-DC4D-4E64-8ABD-D0E3ADD359D1
P2860
Sickle cell disease status and outcomes of African-American men presenting with priapism.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sickle cell disease status and outcomes of African-American men presenting with priapism.
@en
Sickle cell disease status and outcomes of African-American men presenting with priapism.
@nl
type
label
Sickle cell disease status and outcomes of African-American men presenting with priapism.
@en
Sickle cell disease status and outcomes of African-American men presenting with priapism.
@nl
prefLabel
Sickle cell disease status and outcomes of African-American men presenting with priapism.
@en
Sickle cell disease status and outcomes of African-American men presenting with priapism.
@nl
P1476
Sickle cell disease status and outcomes of African-American men presenting with priapism.
@en
P2093
John Mulhall
Nelson Bennett
P304
P356
10.1111/J.1743-6109.2008.00770.X
P577
2008-02-25T00:00:00Z